Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-26 11:59 am Purchase | 2024-03-08 | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAPY | EcoR1 Capital, LLC | 164,424,420 10.700% | 51,000,000![]() (+44.96%) | Filing History |
| 2024-03-11 3:34 pm Purchase | 2024-02-28 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | EcoR1 Capital, LLC | 4,155,375 5.300% | 4,155,375![]() (New Position) | Filing History |
| 2024-02-22 7:01 pm Unchanged | 2024-02-22 | 13D | ZYMEWORKS INC ZYME | EcoR1 Capital, LLC | 14,132,291 19.990% | 0 (Unchanged) | Filing History |
| 2024-02-16 12:54 pm Purchase | 2024-02-05 | 13G | ITEOS THERAPEUTICS INC. ITOS | EcoR1 Capital, LLC | 1,944,672 5.400% | 1,944,672![]() (New Position) | Filing History |
| 2024-02-15 11:38 am Unchanged | 2023-12-31 | 13G | MORPHIC HLDG INC MORF | EcoR1 Capital, LLC | 211,262 0.400% | 0 (Unchanged) | Filing History |
| 2024-02-15 11:35 am Unchanged | 2023-12-31 | 13G | ATEA PHARMACEUTICALS INC AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing History |
| 2024-02-15 09:15 am Unchanged | 2023-12-31 | 13G | ATEA PHARMACEUTICALS INC AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing History |
| 2024-02-14 8:02 pm Purchase | 2023-12-31 | 13G | ATEA PHARMACEUTICALS INC AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 811,000![]() (+13.11%) | Filing History |
| 2024-02-14 7:54 pm Sale | 2023-12-31 | 13G | MORPHIC HLDG INC MORF | EcoR1 Capital, LLC | 211,262 0.400% | -3,740,304![]() (-94.65%) | Filing History |
| 2024-02-14 6:59 pm Purchase | 2023-12-31 | 13G | ZYMEWORKS INC ZYME | EcoR1 Capital, LLC | 14,132,291 19.990% | 694,818![]() (+5.17%) | Filing History |
| 2024-02-14 6:54 pm Unchanged | 2023-12-31 | 13G | XENCOR INC XNCR | EcoR1 Capital, LLC | 5,282,516 8.700% | 0 (Unchanged) | Filing History |
| 2024-02-14 6:49 pm Sale | 2023-12-31 | 13G | TEMPEST THERAPEUTICS INC TPST | EcoR1 Capital, LLC | 0 0.000% | -80,985![]() (Position Closed) | Filing History |
| 2024-02-14 6:45 pm Purchase | 2023-12-31 | 13G | THIRD HARMONIC BIO INC THRD | EcoR1 Capital, LLC | 3,182,444 7.900% | 200,000![]() (+6.71%) | Filing History |
| 2024-02-14 6:41 pm Sale | 2023-12-31 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | EcoR1 Capital, LLC | 0 0.000% | -3,460,208![]() (Position Closed) | Filing History |
| 2024-02-14 6:30 pm Sale | 2023-12-31 | 13G | REVOLUTION MEDICINES INC RVMD | EcoR1 Capital, LLC | 132,579 0.100% | -7,066,121![]() (-98.16%) | Filing History |
| 2024-02-14 6:19 pm Purchase | 2023-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital, LLC | 6,275,210 8.900% | 2,857,142![]() (+83.59%) | Filing History |
| 2024-02-14 6:12 pm Sale | 2023-12-31 | 13G | NGM BIOPHARMACEUTICALS INC NGM | EcoR1 Capital, LLC | 2,385,873 2.900% | -4,049,645![]() (-62.93%) | Filing History |
| 2024-02-14 6:05 pm Purchase | 2023-12-18 | 13G | NEUROGENE INC NGNE | EcoR1 Capital, LLC | 1,282,168 9.990% | 1,239,137![]() (+2879.64%) | Filing History |
| 2024-02-14 5:58 pm Purchase | 2023-12-31 | 13G | KURA ONCOLOGY INC KURA | EcoR1 Capital, LLC | 7,598,797 9.990% | 960,426![]() (+14.47%) | Filing History |
| 2024-02-14 5:53 pm Sale | 2023-12-31 | 13G | JANUX THERAPEUTICS INC JANX | EcoR1 Capital, LLC | 0 0.000% | -3,255,270![]() (Position Closed) | Filing History |

